Your browser does not support java script. Skip navigation
Loading, please wait  Loading, please wait...

Person-Centered Care for Opioid Use Disorder


 

Enhance Your Knowledge Regarding the

TREATMENT OF OPIOID USE DISORDER

with Guidance from Frontline Healthcare Practitioners

 
This series will describe best practices regarding the use of supportive behavioral interventions and FDA-approved medications in Medication-Assisted Treatment (MAT) of opioid use disorder.  It will also address current controversies and ethical issues that sometimes come up in the treatment of opioid use disorder.  This learning opportunity is delivered from a multidisciplinary, team-based perspective, to better explain the successful outcomes that are attainable when a variety of healthcare professionals contribute to the patient-centered treatment process. 
 
This activity meets the Texas State Board of Pharmacy (TSBP) requirement for 1 hour of continuing pharmacy education about opioids.
 
FORMAT 
This program is delivered in a flipped classroom design, which requires participants to complete the online self-paced modules in preparation for the live webinars.  The live webinars provide an opportunity to further discuss the online content via Q&A and case exercises with field experts.  
 
  • There is a Pre-Assessment Test that must be completed to access the remaining modules.  This assessment is not for a grade, but it is a primer for the content that will be covered in the upcoming modules.
  • There are 4 online modules, each consisting of a video-recorded lecture and interactive cases.
  • There are 3 live webinars that offer the opportunity to continue practice applying the course content with feedback from field experts.  
  • You will receive CE credit upon successful completion of each module. Successful completion includes viewing the module, earning 70% or better on the post-test (three attempts), and completing the online evaluation.   
  • You will receive CE credit upon successful completion of each webinar.  Successful completion includes participating in the full webinar and completing the evaluation that will be available after the webinar concludes.  Webinars will consist of 40-60 mintues of Q&A and case discussion.  Each webinar will be directly tied to its corresponding topic/module.  Be sure to complete the online module PRIOR to participating in its assigned webinar.  See complete details in the course outline below.  NOTE: Dates of webinars are subject to change based on faculty schedules, but prior notice will be provided to registrants.
  • See the link at the top of the page "View/Print CE Credit" to view your updated certificates or completed credits (CPE credits are automatically sent to the NABP profile in the learner's "My Profile" tab at the top right of this page).

Log On Instructions for Live Webinars

If you have already registered, and are looking to log in for the live webinars, be sure to click on the "Login" link at the top right-side of this page.  After logging in, click on the "pending programs" link at the top center, and find this course under the LIVE tab.  Click on the name of the course, then click on the Webinar 1 tab in the course.   Follow the instructions for connecting to the webinar.


Facutly

Lucas G. Hill, PharmD, BCPS, BCACP – Program Scientific Chair
Clinical Assistant Professor, College of Pharmacy
Director & Principal Investigator, Operation Naloxone

Caroline Hedenberg, LCSW
Collaborative Care Clinician, CARMAhealth

David Walsh, MSN, RN, PMHNP-BC
Chief Operations Officer, CARMAhealth

Carlos F. Tirado, MD, MPH
Chief Medical Officer, CARMAhealth
Clinical Associate Professor, Dell Medical School

Faculty Disclosures:

  • Lucas G. Hill, PharmD, BCPS, BCACP has no relevant financial interest to disclose.
  • Caroline Hedenberg, LCSW  has no relevant financial interest to disclose.
  • David Walsh, MSN, RN, PMHNP-BC has no relevant financial interest to disclose.
  • Carlos F. Tirado, MD, MPH is the Chief Medical Officer of CARMAhealth.

Date: Sep 1, 2019 01:00 AM - 01:00 AM

Fee

$0.00

CE Hours

6.50

CE Units

0.650

Registration closes on Sep 01, 2021 12:00 AM

Activity Type

  • Knowledge

Target Audience(s)

  • Counselors
  • Pharmacists
  • Physician Assistant
  • Physicians
  • Psychologists
  • Social Workers

Requirements for CE Credit

ACPE Logo
The University of Texas at Austin College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.  This knowledge-based CE activity is a series of online modules and live webinars that is approved for up to 0.650 CEUs (6.50 contact hours) of continuing education credit.  In order to receive 6.50 contact hours of CE credit, the participant must successfully complete the online modules and attend the live webinars.  Successful completion of the online modules includes completion of the pre-test,  viewing module content in its entirety, passing the post-test with a minimum score of 70% within three attempts, and completion of the module evaluation.  To earn CE credit for the live webinars the participant must attend the entire activity, participate in the active learning Q&A and case exercises, and complete the online evaluation.

CME Credit:
The UT Health San Antonio Joe R. & Teresa Lozano Long School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The UT Health San Antonio Joe R. & Teresa Lozano Long School of Medicine designates this enduring material for a maximum of 6.5 AMA PRA Category 1 CreditsTM.
This course has been designated by UT Health San Antonio Joe R. & Teresa Lozano Long School of Medicine for 6.50 credits of education in medical ethics and/or professional responsibility.

Social Work CEUs:
The University of Texas at Austin Hicks School of Social Work, Continuing Education Service has awarded 6.5 contact hour(s) of Continuing Social Work Education. Program represented by this certificate was provided in accordance with the criteria and standards of the Texas State Board of Social Worker Examiners, and has been approved for Social Workers, Licensed Professional Counselors, and Licensed Marriage and Family Therapists. Please note that 1 hour = 1 CEU.  Complaints about this program may be made to TSBSWE, http://www.dshs.state.tx.us/socialwork/

Financial Disclosure:
This activity has been sponsored in-part through an educational grant from Alkermes, Inc.  Individual speaker disclosures are listed below, within their individual module description.

 

 

 

   

ONLINE MODULE START:  Pre-Assessment + Introduction to The Opioid Crisis
Pre-Assessment Test
 
The Pre-Assessment Test (which is not graded) must be completed FIRST, before viewing the Introduction or any other modules. The Pre-Assessment is intended to assess knowledge/perceptions before viewing any content.  Once completed, proceed with the Introduction below.
 
Introduction to the Opioid Crisis
 

Objectives

  • Describe recent national trends in opioid-related morbidity and mortality
  • Consider the unintended consequences of opioid supply reduction interventions

Activity Number

0067-0000-19-130-H01-P

Release Date: Sep 1, 2019
Credit Expiration Date: Sep 1, 2021

CE Hours

0.50
   

   

ONLINE MODULE 1: Supportive Behavioral Interventions
Complete this online self-paced module before participating in LIVE Webinar 1.
This module includes a 1-hour video, PDF copy of presentation slides, post-test, and evaluation for CE credit.  It follows the Flip Classroom design by requiring participants to complete this online self-paced module before participating in LIVE Webinar 1.  The webinar offers the opportunity to engage with the course presenter, ask questions, and work through case examples.  See details about the webinar via the tabs below.

Objectives

  • Describe key principles of SBIRT and MI
  • Identify supportive resources for clinical application of SBIRT and MI
  • Consider implementation of SBIRT and MI in OUD identification and treatment

Activity Number

0067-0000-19-131-H01-P

Release Date: Sep 1, 2019
Credit Expiration Date: Sep 1, 2021

CE Hours

1.00
   

   

ONLINE MODULE 2: Medication-Assisted Recovery 101
Complete this online self-paced module before participating in LIVE Webinar 2.
This module includes a 1-hour video, PDF copy of presentation slides, post-test, and evaluation for CE credit.  It follows the Flip Classroom design by requiring participants to complete this online self-paced module before participating in LIVE Webinar 2.  The webinar offers the opportunity to engage with the course presenter, ask questions, and work through case examples.  See details about the webinar via the tabs below.
 
In this module, the faculty discusses three FDA-approved medications for OUD treatments, compares the basic pharmacology of these FDA-approved treatments, discribes evidence-based data of outcomes, contrasts barriers in accessing these treatments, and discusses the variables impacting these agents and treatments.

Objectives

  • Identify three FDA-approved medications for OUD treatment
  • Compare basic pharmacology of these agents and implications for treatment
  • Describe evidence regarding patient outcomes with these agents
  • Contrast barriers to accessing FDA-approved medications for OUD treatment
  • Consider the variable impact of these agents on access to recovery supports

Activity Number

0067-0000-19-133-H01-P

Release Date: Sep 1, 2019
Credit Expiration Date: Sep 1, 2021

CE Hours

1.00
   

   

ONLINE MODULE 3: Medication-Assisted Recovery 201 and Harm Reduction
Complete this online self-paced module before participating in LIVE Webinar 3.
This module includes a 1-hour video, PDF copy of presentation slides, post-test, and evaluation for CE credit.  It follows the Flip Classroom design by requiring participants to complete this online self-paced module before participating in LIVE Webinar 3.  The webinar offers the opportunity to engage with the course presenter, ask questions, and work through case examples.  See details about the webinar via the tabs below.
 
In this module, the faculty discuss common comorbidities encountered in patients with sever OUD, describe team-based modules for comprehensive treatment of OUT as well as current controversies and ethical issues related to OUT treatment.  Further, they describe the role of naloxone in opioid overdose prevention, additional harm reduction interventions, and evaluate common myths regarding harm reduction interventions.

Objectives

  • Recall common comorbidities encountered in patients with sever OUD
  • Describe team-based models for comprehensive treatment of OUD and comorbidities
  • Discuss current controversies and ethical issues related to OUD treatment
  • Describe the role of naloxone in opioid overdose prevention
  • Discuss additional harm reduction interventions that can be implemented in healthcare settings
  • Evaluate common myths regarding harm reduction interventions

Activity Number

0067-0000-19-135-H01-P

Release Date: Sep 1, 2019
Credit Expiration Date: Sep 1, 2021

CE Hours

1.00
   

 

   

LIVE WEBINAR 1: Supportive Behavioral Interventions
This LIVE webinar is a follow-up discussion to ONLINE MODULE 1: Supportive Behavioral Interventions, led by two field experts who will work through a Q&A session and case exercises.  Be sure to complete ONLINE MODULE 1 prior to participating in this webinar.
This webinar completes the filpped classroom design for the ONLINE MODULE 1: Supportive Behavioral Interventions.  Links to the webinar course are included below.  Registration is required.  If already registered, be sure to log back in to your account.  Once done, the link to the webinar will appear below.

Activity Number

0067-0000-19-132-H01-P
Date: 10/21/19
Time: 12:00 PM - 01:00 PM

CE Hours

1.00
   

 

   

LIVE WEBINAR 2: Medication Assisted Recovery 101
This LIVE webinar is a follow-up discussion to ONLINE MODULE 2: Medication-Assisted Recovery 101, which will be led by two field experts who work through a Q&A session and case exercises.  Be sure to complete ONLINE MODULE 2 prior to participating in this webinar.
This webinar completes the filpped classroom design for the ONLINE MODULE 2: Medication Assisted Recovery 101.  Links to the webinar course are includes below.  Registration is required.  If already registered, be sure to log back in to your account.  Once done, the link to the webinar will appear below.

Activity Number

0067-0000-19-134-H01-P
Date: 12/05/19
Time: 12:00 PM - 01:00 PM

CE Hours

1.00
   

 

   

LIVE WEBINAR 3: Medication Assisted Recovery 201 and Harm Reduction
NOTE:  TENTATIVELY scheduled for December 13, 2019.  Schedule is subject to change.  Final date will be posted before December 1.

This LIVE webinar is a follow-up discussion to ONLINE MODULE 3: Medication-Assisted Recovery 201 and Harm Reduction and will be led by two field experts who work through a Q&A session and case exercises.  Be sure to complete ONLINE MODULE 3 prior to participating in this webinar.
This webinar completes the filpped classroom design for the ONLINE MODULE 3: Medication Assisted Recovery 201 and Harm Reduction.  Links to the webinar course are includes below.  Registration is required.  If already registered, be sure to log back in to your account.  Once done, the link to the webinar will appear below.

Activity Number

0067-0000-19-136-H01-P
Date: 12/13/19
Time: 12:00 PM - 01:00 PM

CE Hours

1.00